Agricultural biotechnology research: Practices, consequences, and policy recommendations

1988 ◽  
Vol 5 (3) ◽  
pp. 3-14 ◽  
Author(s):  
William B. Lacy ◽  
Laura R. Lacy ◽  
Lawrence Busch
1997 ◽  
Vol 26 (2) ◽  
pp. 79-85 ◽  
Author(s):  
Mario C. Demicheli

Set for success in the market, biotechnology could fulfil several objectives of the European Union, notably those relating to health, agriculture, the environment, technological development and general business competitiveness. However, several factors hinderthis knowledge-based technology from realizing its potential in Europe, as is measured by the usual indicators of competitiveness. The reasons are examined through a bottom-up approach, starting from the management of biotechnology research and moving towards business strategy and the role of consumers and regulators. Agricultural biotechnology in Europe is characterized by excellence in research but unattractiveness to investors.


2011 ◽  
Vol 3 (1) ◽  
Author(s):  
Thomas Ayo Adisa ◽  
Adegbenga E Adekoya ◽  
Udom E Inyeneh ◽  
Isaac Auta Toro ◽  
Edore Thomas Akpokodje ◽  
...  

2018 ◽  
Vol 17 (02) ◽  
pp. A04 ◽  
Author(s):  
Asheley R. Landrum ◽  
Joseph Hilgard ◽  
Robert B. Lull ◽  
Heather Akin ◽  
Kathleen Hall Jamieson

Public trust in agricultural biotechnology organizations that produce so-called ‘genetically-modified organisms’ (GMOs) is affected by misinformed attacks on GM technology and worry that producers' concern for profits overrides concern for the public good. In an experiment, we found that reporting that the industry engages in open and transparent research practices increased the perceived trustworthiness of university and corporate organizations involved with GMOs. Universities were considered more trustworthy than corporations overall, supporting prior findings in other technology domains. The results suggest that commitment to, and communication of, open and transparent research practices should be part of the process of implementing agricultural biotechnologies.


2019 ◽  
Author(s):  
Asheley R. Landrum ◽  
Joseph Hilgard ◽  
Robert Lull ◽  
Heather Akin

Public trust in agricultural biotechnology organizations that produce so-called ‘genetically-modified organisms’ (GMOs) is affected by misinformed attacks on GM technology and worry that producers' concern for profits overrides concern for the public good. In an experiment, we found that reporting that the industry engages in open and transparent research practices increased the perceived trustworthiness of university and corporate organizations involved with GMOs. Universities were considered more trustworthy than corporations overall, supporting prior findings in other technology domains. The results suggest that commitment to, and communication of, open and transparent research practices should be part of the process of implementing agricultural biotechnologies.


Sign in / Sign up

Export Citation Format

Share Document